APO Research
Talk to an analyst

APO RESEARCH · REPORT

Safety Lancets

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

Selected research

Market Analysis & Forecast

Global Safety Lancets Market Analysis and Forecast 2026-2032

21 December 2025193 pages

Choose your research edition.

Industry ResearchSafety Lancets Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Safety Lancets Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Safety Lancets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Safety Lancets Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Safety Lancets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

Global Safety Lancets key players include BD, Greiner Bio One, B. Braun, etc. Global top 3 manufacturers hold a share over 52%.

Europe is the largest market, with a share about 35%, followed by North America and Asia Pacific, have a share about 30% and 26%.

Read the full market overview

In terms of product, soft blood collection needle is the largest segment, with a share over 77%. And in terms of application, the largest application is hospital and clinics, followed by diagnostic centers.

This report presents an overview of global market for Safety Lancets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Safety Lancets, also provides the sales of main regions and countries. Of the upcoming market potential for Safety Lancets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Safety Lancets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Safety Lancets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Safety Lancets sales, projected growth trends, production technology, application and end-user industry.

Safety Lancets Segment by Company

BD

Greiner Bio One

B. Braun

Terumo

Nipro

Sarstedt

Smiths Medical

贝普医疗科技

三力集团

康德莱

山东威高

广州阳普

Safety Lancets Segment by Type

Soft Blood Collection Needle

Rigid Blood Collection Needle

Safety Lancets Segment by Application

Hospital and Clinics

Diagnostic Centers

Others

Safety Lancets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Safety Lancets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Safety Lancets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Safety Lancets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Safety Lancets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Safety Lancets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Safety Lancets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Safety Lancets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Soft Blood Collection Needle Major Manufacturers Table 3. Rigid Blood Collection Needle Major Manufacturers Table 4. Global Safety Lancets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital and Clinics Major Manufacturers Table 6. Diagnostic Centers Major Manufacturers Table 7. Others Major Manufacturers Table 8. Safety Lancets Industry Trends Table 9. Safety Lancets Industry Drivers Table 10. Safety Lancets Industry Opportunities and Challenges Table 11. Safety Lancets Industry Restraints Table 12. Global Safety Lancets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Safety Lancets Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Safety Lancets Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Safety Lancets Revenue Market Share by Region (2021-2026) Table 16. Global Safety Lancets Revenue Market Share by Region (2027-2032) Table 17. Global Safety Lancets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M units) Table 18. Global Safety Lancets Sales by Region (2021-2026) & (M units) Table 19. Global Safety Lancets Sales by Region (2027-2032) & (M units) Table 20. Global Safety Lancets Sales Market Share by Region (2021-2026) Table 21. Global Safety Lancets Sales Market Share by Region (2027-2032) Table 22. Global Safety Lancets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Safety Lancets Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Safety Lancets Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Safety Lancets Sales Market Share by Manufacturers (2021-2026) Table 26. Global Safety Lancets Sales Price (USD/K unit) of Manufacturers (2021-2026) Table 27. Global Safety Lancets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Safety Lancets Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Safety Lancets Manufacturers, Product Type & Application Table 30. Global Safety Lancets Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Safety Lancets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Safety Lancets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Safety Lancets Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Safety Lancets Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Safety Lancets Revenue Market Share by Type (2021-2026) Table 37. Global Safety Lancets Revenue Market Share by Type (2027-2032) Table 38. Global Safety Lancets Sales by Type 2021 VS 2025 VS 2032 (M units) Table 39. Global Safety Lancets Sales by Type (2021-2026) & (M units) Table 40. Global Safety Lancets Sales by Type (2027-2032) & (M units) Table 41. Global Safety Lancets Sales Market Share by Type (2021-2026) Table 42. Global Safety Lancets Sales Market Share by Type (2027-2032) Table 43. Global Safety Lancets Price by Type (2021-2026) & (USD/K unit) Table 44. Global Safety Lancets Price by Type (2027-2032) & (USD/K unit) Table 45. Global Safety Lancets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Safety Lancets Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Safety Lancets Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Safety Lancets Revenue Market Share by Application (2021-2026) Table 49. Global Safety Lancets Revenue Market Share by Application (2027-2032) Table 50. Global Safety Lancets Sales by Application 2021 VS 2025 VS 2032 (M units) Table 51. Global Safety Lancets Sales by Application (2021-2026) & (M units) Table 52. Global Safety Lancets Sales by Application (2027-2032) & (M units) Table 53. Global Safety Lancets Sales Market Share by Application (2021-2026) Table 54. Global Safety Lancets Sales Market Share by Application (2027-2032) Table 55. Global Safety Lancets Price by Application (2021-2026) & (USD/K unit) Table 56. Global Safety Lancets Price by Application (2027-2032) & (USD/K unit) Table 57. BD Company Information Table 58. BD Business Overview Table 59. BD Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 60. BD Safety Lancets Product Portfolio Table 61. BD Recent Development Table 62. Greiner Bio One Company Information Table 63. Greiner Bio One Business Overview Table 64. Greiner Bio One Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 65. Greiner Bio One Safety Lancets Product Portfolio Table 66. Greiner Bio One Recent Development Table 67. B. Braun Company Information Table 68. B. Braun Business Overview Table 69. B. Braun Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 70. B. Braun Safety Lancets Product Portfolio Table 71. B. Braun Recent Development Table 72. Terumo Company Information Table 73. Terumo Business Overview Table 74. Terumo Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 75. Terumo Safety Lancets Product Portfolio Table 76. Terumo Recent Development Table 77. Nipro Company Information Table 78. Nipro Business Overview Table 79. Nipro Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 80. Nipro Safety Lancets Product Portfolio Table 81. Nipro Recent Development Table 82. Sarstedt Company Information Table 83. Sarstedt Business Overview Table 84. Sarstedt Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 85. Sarstedt Safety Lancets Product Portfolio Table 86. Sarstedt Recent Development Table 87. Smiths Medical Company Information Table 88. Smiths Medical Business Overview Table 89. Smiths Medical Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 90. Smiths Medical Safety Lancets Product Portfolio Table 91. Smiths Medical Recent Development Table 92. 贝普医疗科技 Company Information Table 93. 贝普医疗科技 Business Overview Table 94. 贝普医疗科技 Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 95. 贝普医疗科技 Safety Lancets Product Portfolio Table 96. 贝普医疗科技 Recent Development Table 97. 三力集团 Company Information Table 98. 三力集团 Business Overview Table 99. 三力集团 Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 100. 三力集团 Safety Lancets Product Portfolio Table 101. 三力集团 Recent Development Table 102. 康德莱 Company Information Table 103. 康德莱 Business Overview Table 104. 康德莱 Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 105. 康德莱 Safety Lancets Product Portfolio Table 106. 康德莱 Recent Development Table 107. 山东威高 Company Information Table 108. 山东威高 Business Overview Table 109. 山东威高 Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 110. 山东威高 Safety Lancets Product Portfolio Table 111. 山东威高 Recent Development Table 112. 广州阳普 Company Information Table 113. 广州阳普 Business Overview Table 114. 广州阳普 Safety Lancets Sales (M units), Revenue (US$ Million), Price (USD/K unit) and Gross Margin (2021-2026) Table 115. 广州阳普 Safety Lancets Product Portfolio Table 116. 广州阳普 Recent Development Table 117. North America Safety Lancets Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Safety Lancets Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Safety Lancets Sales by Type (2021-2026) & (M units) Table 120. North America Safety Lancets Sales by Type (2027-2032) & (M units) Table 121. North America Safety Lancets Sales Price by Type (2021-2026) & (USD/K unit) Table 122. North America Safety Lancets Sales Price by Type (2027-2032) & (USD/K unit) Table 123. North America Safety Lancets Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Safety Lancets Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Safety Lancets Sales by Application (2021-2026) & (M units) Table 126. North America Safety Lancets Sales by Application (2027-2032) & (M units) Table 127. North America Safety Lancets Sales Price by Application (2021-2026) & (USD/K unit) Table 128. North America Safety Lancets Sales Price by Application (2027-2032) & (USD/K unit) Table 129. North America Safety Lancets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Safety Lancets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Safety Lancets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Safety Lancets Sales by Country (2021 VS 2025 VS 2032) & (M units) Table 133. North America Safety Lancets Sales by Country (2021-2026) & (M units) Table 134. North America Safety Lancets Sales by Country (2027-2032) & (M units) Table 135. North America Safety Lancets Sales Price by Country (2021-2026) & (USD/K unit) Table 136. North America Safety Lancets Sales Price by Country (2027-2032) & (USD/K unit) Table 137. United States Safety Lancets Revenue (2021-2032) & (US$ Million) Table 138. Canada Safety Lancets Revenue (2021-2032) & (US$ Million) Table 139. Mexico Safety Lancets Revenue (2021-2032) & (US$ Million) Table 140. Europe Safety Lancets Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Safety Lancets Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Safety Lancets Sales by Type (2021-2026) & (M units) Table 143. Europe Safety Lancets Sales by Type (2027-2032) & (M units) Table 144. Europe Safety Lancets Sales Price by Type (2021-2026) & (USD/K unit) Table 145. Europe Safety Lancets Sales Price by Type (2027-2032) & (USD/K unit) Table 146. Europe Safety Lancets Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Safety Lancets Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Safety Lancets Sales by Application (2021-2026) & (M units) Table 149. Europe Safety Lancets Sales by Application (2027-2032) & (M units) Table 150. Europe Safety Lancets Sales Price by Application (2021-2026) & (USD/K unit) Table 151. Europe Safety Lancets Sales Price by Application (2027-2032) & (USD/K unit) Table 152. Europe Safety Lancets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Safety Lancets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Europe Safety Lancets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Europe Safety Lancets Sales by Country (2021 VS 2025 VS 2032) & (M units) Table 156. Europe Safety Lancets Sales by Country (2021-2026) & (M units) Table 157. Europe Safety Lancets Sales by Country (2027-2032) & (M units) Table 158. Europe Safety Lancets Sales Price by Country (2021-2026) & (USD/K unit) Table 159. Europe Safety Lancets Sales Price by Country (2027-2032) & (USD/K unit) Table 160. Germany Safety Lancets Revenue (2021-2032) & (US$ Million) Table 161. France Safety Lancets Revenue (2021-2032) & (US$ Million) Table 162. U.K. Safety Lancets Revenue (2021-2032) & (US$ Million) Table 163. Italy Safety Lancets Revenue (2021-2032) & (US$ Million) Table 164. Russia Safety Lancets Revenue (2021-2032) & (US$ Million) Table 165. Spain Safety Lancets Revenue (2021-2032) & (US$ Million) Table 166. Netherlands Safety Lancets Revenue (2021-2032) & (US$ Million) Table 167. Switzerland Safety Lancets Revenue (2021-2032) & (US$ Million) Table 168. Sweden Safety Lancets Revenue (2021-2032) & (US$ Million) Table 169. Poland Safety Lancets Revenue (2021-2032) & (US$ Million) Table 170. China Safety Lancets Revenue by Type (2021-2026) & (US$ Million) Table 171. China Safety Lancets Revenue by Type (2027-2032) & (US$ Million) Table 172. China Safety Lancets Sales by Type (2021-2026) & (M units) Table 173. China Safety Lancets Sales by Type (2027-2032) & (M units) Table 174. China Safety Lancets Sales Price by Type (2021-2026) & (USD/K unit) Table 175. China Safety Lancets Sales Price by Type (2027-2032) & (USD/K unit) Table 176. China Safety Lancets Revenue by Application (2021-2026) & (US$ Million) Table 177. China Safety Lancets Revenue by Application (2027-2032) & (US$ Million) Table 178. China Safety Lancets Sales by Application (2021-2026) & (M units) Table 179. China Safety Lancets Sales by Application (2027-2032) & (M units) Table 180. China Safety Lancets Sales Price by Application (2021-2026) & (USD/K unit) Table 181. China Safety Lancets Sales Price by Application (2027-2032) & (USD/K unit) Table 182. Asia Safety Lancets Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Safety Lancets Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Safety Lancets Sales by Type (2021-2026) & (M units) Table 185. Asia Safety Lancets Sales by Type (2027-2032) & (M units) Table 186. Asia Safety Lancets Sales Price by Type (2021-2026) & (USD/K unit) Table 187. Asia Safety Lancets Sales Price by Type (2027-2032) & (USD/K unit) Table 188. Asia Safety Lancets Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Safety Lancets Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Safety Lancets Sales by Application (2021-2026) & (M units) Table 191. Asia Safety Lancets Sales by Application (2027-2032) & (M units) Table 192. Asia Safety Lancets Sales Price by Application (2021-2026) & (USD/K unit) Table 193. Asia Safety Lancets Sales Price by Application (2027-2032) & (USD/K unit) Table 194. Asia Safety Lancets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Safety Lancets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Safety Lancets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Safety Lancets Sales by Country (2021 VS 2025 VS 2032) & (M units) Table 198. Asia Safety Lancets Sales by Country (2021-2026) & (M units) Table 199. Asia Safety Lancets Sales by Country (2027-2032) & (M units) Table 200. Asia Safety Lancets Sales Price by Country (2021-2026) & (USD/K unit) Table 201. Asia Safety Lancets Sales Price by Country (2027-2032) & (USD/K unit) Table 202. Japan Safety Lancets Revenue (2021-2032) & (US$ Million) Table 203. South Korea Safety Lancets Revenue (2021-2032) & (US$ Million) Table 204. India Safety Lancets Revenue (2021-2032) & (US$ Million) Table 205. Australia Safety Lancets Revenue (2021-2032) & (US$ Million) Table 206. Taiwan Safety Lancets Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Safety Lancets Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Safety Lancets Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Safety Lancets Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Safety Lancets Sales by Type (2021-2026) & (M units) Table 211. SAMEA Safety Lancets Sales by Type (2027-2032) & (M units) Table 212. SAMEA Safety Lancets Sales Price by Type (2021-2026) & (USD/K unit) Table 213. SAMEA Safety Lancets Sales Price by Type (2027-2032) & (USD/K unit) Table 214. SAMEA Safety Lancets Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Safety Lancets Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Safety Lancets Sales by Application (2021-2026) & (M units) Table 217. SAMEA Safety Lancets Sales by Application (2027-2032) & (M units) Table 218. SAMEA Safety Lancets Sales Price by Application (2021-2026) & (USD/K unit) Table 219. SAMEA Safety Lancets Sales Price by Application (2027-2032) & (USD/K unit) Table 220. SAMEA Safety Lancets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Safety Lancets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Safety Lancets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Safety Lancets Sales by Country (2021 VS 2025 VS 2032) & (M units) Table 224. SAMEA Safety Lancets Sales by Country (2021-2026) & (M units) Table 225. SAMEA Safety Lancets Sales by Country (2027-2032) & (M units) Table 226. SAMEA Safety Lancets Sales Price by Country (2021-2026) & (USD/K unit) Table 227. SAMEA Safety Lancets Sales Price by Country (2027-2032) & (USD/K unit) Table 228. Brazil Safety Lancets Revenue (2021-2032) & (US$ Million) Table 229. Argentina Safety Lancets Revenue (2021-2032) & (US$ Million) Table 230. Chile Safety Lancets Revenue (2021-2032) & (US$ Million) Table 231. Colombia Safety Lancets Revenue (2021-2032) & (US$ Million) Table 232. Peru Safety Lancets Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Safety Lancets Revenue (2021-2032) & (US$ Million) Table 234. Israel Safety Lancets Revenue (2021-2032) & (US$ Million) Table 235. UAE Safety Lancets Revenue (2021-2032) & (US$ Million) Table 236. Turkey Safety Lancets Revenue (2021-2032) & (US$ Million) Table 237. Iran Safety Lancets Revenue (2021-2032) & (US$ Million) Table 238. Egypt Safety Lancets Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Safety Lancets Distributors List Table 242. Safety Lancets Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Safety Lancets Image Figure 2. Global Safety Lancets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Safety Lancets Market Size Share 2021 VS 2025 VS 2032 Figure 4. Soft Blood Collection Needle Image Figure 5. Rigid Blood Collection Needle Image Figure 6. Global Safety Lancets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Safety Lancets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital and Clinics Image Figure 9. Diagnostic Centers Image Figure 10. Others Image Figure 11. Global Safety Lancets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Safety Lancets Revenue (2021-2032) & (US$ Million) Figure 13. Global Safety Lancets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Safety Lancets Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Safety Lancets Revenue Market Share by Region (2021-2032) Figure 16. Global Safety Lancets Sales (2021-2032) & (M units) Figure 17. Global Safety Lancets Sales by Region: 2021 VS 2025 VS 2032 (M units) Figure 18. Global Safety Lancets Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Safety Lancets Sales YoY (2021-2032) & (M units) Figure 20. Europe Safety Lancets Sales YoY (2021-2032) & (M units) Figure 21. China Safety Lancets Sales YoY (2021-2032) & (M units) Figure 22. Asia (Excluding China) Safety Lancets Sales YoY (2021-2032) & (M units) Figure 23. South America, Middle East and Africa Safety Lancets Sales YoY (2021-2032) & (M units) Figure 24. Global Safety Lancets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Safety Lancets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Safety Lancets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Safety Lancets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Safety Lancets Revenue Market Share by Type (2021-2032) Figure 30. Global Safety Lancets Sales by Type (2021 VS 2025 VS 2032) & (M units) Figure 31. Global Safety Lancets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Safety Lancets Sales Market Share by Type (2021-2032) Figure 33. Global Safety Lancets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Safety Lancets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Safety Lancets Revenue Market Share by Application (2021-2032) Figure 36. Global Safety Lancets Sales by Application (2021 VS 2025 VS 2032) & (M units) Figure 37. Global Safety Lancets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Safety Lancets Sales Market Share by Application (2021-2032) Figure 39. North America Safety Lancets Revenue Share by Type (2021-2032) Figure 40. North America Safety Lancets Sales Share by Type (2021-2032) Figure 41. North America Safety Lancets Revenue Share by Application (2021-2032) Figure 42. North America Safety Lancets Sales Share by Application (2021-2032) Figure 43. North America Safety Lancets Revenue Share by Country (2021-2032) Figure 44. North America Safety Lancets Sales Share by Country (2021-2032) Figure 45. Europe Safety Lancets Revenue Share by Type (2021-2032) Figure 46. Europe Safety Lancets Sales Share by Type (2021-2032) Figure 47. Europe Safety Lancets Revenue Share by Application (2021-2032) Figure 48. Europe Safety Lancets Sales Share by Application (2021-2032) Figure 49. Europe Safety Lancets Revenue Share by Country (2021-2032) Figure 50. Europe Safety Lancets Sales Share by Country (2021-2032) Figure 51. China Safety Lancets Revenue Share by Type (2021-2032) Figure 52. China Safety Lancets Sales Share by Type (2021-2032) Figure 53. China Safety Lancets Revenue Share by Application (2021-2032) Figure 54. China Safety Lancets Sales Share by Application (2021-2032) Figure 55. Asia Safety Lancets Revenue Share by Type (2021-2032) Figure 56. Asia Safety Lancets Sales Share by Type (2021-2032) Figure 57. Asia Safety Lancets Revenue Share by Application (2021-2032) Figure 58. Asia Safety Lancets Sales Share by Application (2021-2032) Figure 59. Asia Safety Lancets Revenue Share by Country (2021-2032) Figure 60. Asia Safety Lancets Sales Share by Country (2021-2032) Figure 61. SAMEA Safety Lancets Revenue Share by Type (2021-2032) Figure 62. SAMEA Safety Lancets Sales Share by Type (2021-2032) Figure 63. SAMEA Safety Lancets Revenue Share by Application (2021-2032) Figure 64. SAMEA Safety Lancets Sales Share by Application (2021-2032) Figure 65. SAMEA Safety Lancets Revenue Share by Country (2021-2032) Figure 66. SAMEA Safety Lancets Sales Share by Country (2021-2032) Figure 67. Safety Lancets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Safety Lancets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Soft Blood Collection Needle
  • Rigid Blood Collection Needle
Applications
  • Hospital and Clinics
  • Diagnostic Centers
  • Others
Companies covered
  • BD
  • Greiner Bio One
  • B. Braun
  • Terumo
  • Nipro
  • Sarstedt
  • Smiths Medical
  • 贝普医疗科技
  • 三力集团
  • 康德莱
  • 山东威高
  • 广州阳普

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Safety Lancets Market by Type
  3. 1.2.1 Global Safety Lancets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Soft Blood Collection Needle
  5. 1.2.3 Rigid Blood Collection Needle
  6. 1.3 Safety Lancets Market by Application
  7. 1.3.1 Global Safety Lancets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital and Clinics
  9. 1.3.3 Diagnostic Centers
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Safety Lancets Market Dynamics
  1. 2.1 Safety Lancets Industry Trends
  2. 2.2 Safety Lancets Industry Drivers
  3. 2.3 Safety Lancets Industry Opportunities and Challenges
  4. 2.4 Safety Lancets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Safety Lancets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Safety Lancets Revenue by Region
  3. 3.2.1 Global Safety Lancets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Safety Lancets Revenue by Region (2021-2026)
  5. 3.2.3 Global Safety Lancets Revenue by Region (2027-2032)
  6. 3.2.4 Global Safety Lancets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Safety Lancets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Safety Lancets Sales by Region
  9. 3.4.1 Global Safety Lancets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Safety Lancets Sales by Region (2021-2026)
  11. 3.4.3 Global Safety Lancets Sales by Region (2027-2032)
  12. 3.4.4 Global Safety Lancets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Safety Lancets Revenue by Manufacturers
  2. 4.1.1 Global Safety Lancets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Safety Lancets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Safety Lancets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Safety Lancets Sales by Manufacturers
  6. 4.2.1 Global Safety Lancets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Safety Lancets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Safety Lancets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Safety Lancets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Safety Lancets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Safety Lancets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Safety Lancets Manufacturers, Product Type & Application
  13. 4.7 Global Safety Lancets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Safety Lancets Market CR5 and HHI
  16. 4.8.2 2025 Safety Lancets Tier 1, Tier 2, and Tier 3
5 Safety Lancets Market by Type
  1. 5.1 Global Safety Lancets Revenue by Type
  2. 5.1.1 Global Safety Lancets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Safety Lancets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Safety Lancets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Safety Lancets Sales by Type
  6. 5.2.1 Global Safety Lancets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Safety Lancets Sales by Type (2021-2032) & (M units)
  8. 5.2.3 Global Safety Lancets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Safety Lancets Price by Type
6 Safety Lancets Market by Application
  1. 6.1 Global Safety Lancets Revenue by Application
  2. 6.1.1 Global Safety Lancets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Safety Lancets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Safety Lancets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Safety Lancets Sales by Application
  6. 6.2.1 Global Safety Lancets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Safety Lancets Sales by Application (2021-2032) & (M units)
  8. 6.2.3 Global Safety Lancets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Safety Lancets Price by Application
7 Company Profiles
  1. 7.1 BD
  2. 7.1.1 BD Company Information
  3. 7.1.2 BD Business Overview
  4. 7.1.3 BD Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 BD Safety Lancets Product Portfolio
  6. 7.1.5 BD Recent Developments
  7. 7.2 Greiner Bio One
  8. 7.2.1 Greiner Bio One Company Information
  9. 7.2.2 Greiner Bio One Business Overview
  10. 7.2.3 Greiner Bio One Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Greiner Bio One Safety Lancets Product Portfolio
  12. 7.2.5 Greiner Bio One Recent Developments
  13. 7.3 B. Braun
  14. 7.3.1 B. Braun Company Information
  15. 7.3.2 B. Braun Business Overview
  16. 7.3.3 B. Braun Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 B. Braun Safety Lancets Product Portfolio
  18. 7.3.5 B. Braun Recent Developments
  19. 7.4 Terumo
  20. 7.4.1 Terumo Company Information
  21. 7.4.2 Terumo Business Overview
  22. 7.4.3 Terumo Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Terumo Safety Lancets Product Portfolio
  24. 7.4.5 Terumo Recent Developments
  25. 7.5 Nipro
  26. 7.5.1 Nipro Company Information
  27. 7.5.2 Nipro Business Overview
  28. 7.5.3 Nipro Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Nipro Safety Lancets Product Portfolio
  30. 7.5.5 Nipro Recent Developments
  31. 7.6 Sarstedt
  32. 7.6.1 Sarstedt Company Information
  33. 7.6.2 Sarstedt Business Overview
  34. 7.6.3 Sarstedt Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sarstedt Safety Lancets Product Portfolio
  36. 7.6.5 Sarstedt Recent Developments
  37. 7.7 Smiths Medical
  38. 7.7.1 Smiths Medical Company Information
  39. 7.7.2 Smiths Medical Business Overview
  40. 7.7.3 Smiths Medical Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Smiths Medical Safety Lancets Product Portfolio
  42. 7.7.5 Smiths Medical Recent Developments
  43. 7.8 贝普医疗科技
  44. 7.8.1 贝普医疗科技 Company Information
  45. 7.8.2 贝普医疗科技 Business Overview
  46. 7.8.3 贝普医疗科技 Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 贝普医疗科技 Safety Lancets Product Portfolio
  48. 7.8.5 贝普医疗科技 Recent Developments
  49. 7.9 三力集团
  50. 7.9.1 三力集团 Company Information
  51. 7.9.2 三力集团 Business Overview
  52. 7.9.3 三力集团 Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 三力集团 Safety Lancets Product Portfolio
  54. 7.9.5 三力集团 Recent Developments
  55. 7.10 康德莱
  56. 7.10.1 康德莱 Company Information
  57. 7.10.2 康德莱 Business Overview
  58. 7.10.3 康德莱 Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 康德莱 Safety Lancets Product Portfolio
  60. 7.10.5 康德莱 Recent Developments
  61. 7.11 山东威高
  62. 7.11.1 山东威高 Company Information
  63. 7.11.2 山东威高 Business Overview
  64. 7.11.3 山东威高 Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 山东威高 Safety Lancets Product Portfolio
  66. 7.11.5 山东威高 Recent Developments
  67. 7.12 广州阳普
  68. 7.12.1 广州阳普 Company Information
  69. 7.12.2 广州阳普 Business Overview
  70. 7.12.3 广州阳普 Safety Lancets Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 广州阳普 Safety Lancets Product Portfolio
  72. 7.12.5 广州阳普 Recent Developments
8 North America
  1. 8.1 North America Safety Lancets Market Size by Type
  2. 8.1.1 North America Safety Lancets Revenue by Type (2021-2032)
  3. 8.1.2 North America Safety Lancets Sales by Type (2021-2032)
  4. 8.1.3 North America Safety Lancets Price by Type (2021-2032)
  5. 8.2 North America Safety Lancets Market Size by Application
  6. 8.2.1 North America Safety Lancets Revenue by Application (2021-2032)
  7. 8.2.2 North America Safety Lancets Sales by Application (2021-2032)
  8. 8.2.3 North America Safety Lancets Price by Application (2021-2032)
  9. 8.3 North America Safety Lancets Market Size by Country
  10. 8.3.1 North America Safety Lancets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Safety Lancets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Safety Lancets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Safety Lancets Market Size by Type
  2. 9.1.1 Europe Safety Lancets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Safety Lancets Sales by Type (2021-2032)
  4. 9.1.3 Europe Safety Lancets Price by Type (2021-2032)
  5. 9.2 Europe Safety Lancets Market Size by Application
  6. 9.2.1 Europe Safety Lancets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Safety Lancets Sales by Application (2021-2032)
  8. 9.2.3 Europe Safety Lancets Price by Application (2021-2032)
  9. 9.3 Europe Safety Lancets Market Size by Country
  10. 9.3.1 Europe Safety Lancets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Safety Lancets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Safety Lancets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Safety Lancets Market Size by Type
  2. 10.1.1 China Safety Lancets Revenue by Type (2021-2032)
  3. 10.1.2 China Safety Lancets Sales by Type (2021-2032)
  4. 10.1.3 China Safety Lancets Price by Type (2021-2032)
  5. 10.2 China Safety Lancets Market Size by Application
  6. 10.2.1 China Safety Lancets Revenue by Application (2021-2032)
  7. 10.2.2 China Safety Lancets Sales by Application (2021-2032)
  8. 10.2.3 China Safety Lancets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Safety Lancets Market Size by Type
  2. 11.1.1 Asia Safety Lancets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Safety Lancets Sales by Type (2021-2032)
  4. 11.1.3 Asia Safety Lancets Price by Type (2021-2032)
  5. 11.2 Asia Safety Lancets Market Size by Application
  6. 11.2.1 Asia Safety Lancets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Safety Lancets Sales by Application (2021-2032)
  8. 11.2.3 Asia Safety Lancets Price by Application (2021-2032)
  9. 11.3 Asia Safety Lancets Market Size by Country
  10. 11.3.1 Asia Safety Lancets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Safety Lancets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Safety Lancets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Safety Lancets Market Size by Type
  2. 12.1.1 SAMEA Safety Lancets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Safety Lancets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Safety Lancets Price by Type (2021-2032)
  5. 12.2 SAMEA Safety Lancets Market Size by Application
  6. 12.2.1 SAMEA Safety Lancets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Safety Lancets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Safety Lancets Price by Application (2021-2032)
  9. 12.3 SAMEA Safety Lancets Market Size by Country
  10. 12.3.1 SAMEA Safety Lancets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Safety Lancets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Safety Lancets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Safety Lancets Value Chain Analysis
  2. 13.1.1 Safety Lancets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Safety Lancets Production Mode & Process
  6. 13.2 Safety Lancets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Safety Lancets Distributors
  9. 13.2.3 Safety Lancets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst